Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Booster Epidemiological Evaluation of Health, Illness and Vaccine Efficacy Study: Randomized Trial to Compare the Clinical Efficacy of Novavax vs. mRNA COVID-19 2023-2024 Updated Vaccines Among Adults in the United States

NCT06065176 is registered in ClinicalTrials.gov with Sarang K. Yoon, DO, MOH as lead sponsor.

NCT NCT06065176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06065176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Booster Epidemiological Evaluation of Health, Illness and Vaccine Efficacy Study: Randomized Trial to Compare the Clinical Efficacy of Novavax vs. mRNA COVID-19 2023-2024 Updated Vaccines Among Adults in the United States
Lead sponsor
Sarang K. Yoon, DO, MOH
Phase
Phase 4
Overall status
Completed
Start date
November 22, 2023
Completion date
September 9, 2024
Enrollment
1,188 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars cov 2 infection, upper respiratory disease, upper respiratory tract infection, vaccine-preventable diseases